about
Meeting report: applied biopharmaceutics and quality by design for dissolution/release specification setting: product quality for patient benefitRhamnogalacturonan-I Based Microcapsules for Targeted Drug ReleaseAnalysis of 3D Prints by X-ray Computed Microtomography and Terahertz Pulsed Imaging.Spatial confinement can lead to increased stability of amorphous indomethacin.Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides.Enzymatic characterization of lipid-based drug delivery systems.Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.Bioavailability of seocalcitol III. Administration of lipid-based formulations to minipigs in the fasted and fed state.In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks.Clinical studies with oral lipid based formulations of poorly soluble compoundsIn vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate.Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levelsCharacterising lipid lipolysis and its implication in lipid-based formulation development.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems.Oral delivery of peptides and proteins using lipid-based drug delivery systems.Lipid-based formulations for oral administration of poorly water-soluble drugs.Bile salts and their importance for drug absorption.In vitro models for the prediction of in vivo performance of oral dosage forms.Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.Studying furosemide solubilization using an in vitro model simulating gastrointestinal digestion and drug solubilization in neonates and young infants.Using Potentiometric Free Drug Sensors to Determine the Free Concentration of Ionizable Drugs in Colloidal Systems.Apomorphine and its esters: Differences in Caco-2 cell permeability and chylomicron affinity.In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems.In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).pH-triggered drug release from biodegradable microwells for oral drug delivery.High-Throughput Lipolysis in 96-Well Plates for Rapid Screening of Lipid-Based Drug Delivery Systems.Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase.Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption.Comparison of lipases for in vitro models of gastric digestion: lipolysis using two infant formulas as model substrates.Buccal absorption of diazepam is improved when administered in bioadhesive tablets-An in vivo study in conscious Göttingen mini-pigs.In Vivo Precipitation of Poorly Soluble Drugs from Lipid-Based Drug Delivery Systems.Studying the Propensity of Compounds to Supersaturate: A Practical and Broadly Applicable Approach.A novel excipient, 1-perfluorohexyloctane shows limited utility for the oral delivery of poorly water-soluble drugs.Interlaboratory Validation of Small-Scale Solubility and Dissolution Measurements of Poorly Water-Soluble Drugs.Effect of food intake and co-administration of placebo self-nanoemulsifying drug delivery systems on the absorption of cinnarizine in healthy human volunteers.Anhydrate to hydrate solid-state transformations of carbamazepine and nitrofurantoin in biorelevant media studied in situ using time-resolved synchrotron X-ray diffraction.
P50
Q24622781-11F36478-BB08-4C0A-B8A8-A86A220E4993Q28555107-3784FD96-F2F1-414E-95B1-E81B1411CA76Q30844294-B02A9E62-0269-42DA-B73E-A627674DB8EFQ34240950-6F1D1BB9-CFBF-4712-8B34-173C85CFE66BQ34246873-8D8ED610-9219-4836-B5A3-ED823BE849A2Q34429030-012B9BDA-3667-421D-B960-B6ADDAF8D76FQ34519807-AD9460DA-C40D-4E20-8357-CEF8035580ADQ34611987-3A4C962F-63F7-4578-8467-0D273B292D72Q34764690-A70B26A5-0008-46FB-96FB-774F722C7239Q34778043-BE98BDB2-F656-4C44-9266-82FFDFEFFA15Q35136316-B79268F0-C606-47F8-9E07-E6425087F2E1Q35318247-6A1F69A1-DD10-4124-A682-C2611CBEC204Q36331543-3C821C1C-4654-49E1-AF32-A1630DDC5A6FQ37805592-EBB478F4-4DDB-46DB-A9F8-5E0D284F6918Q37805595-797E89C0-F949-4A04-922A-B01F0D59F7B0Q37851640-D6D48682-3A08-499C-8F23-BAEC5E2E9F29Q38035036-25A1CF83-F505-4843-93D2-4195072D42B6Q38098332-34597CCA-0DA8-471C-9B2A-D0FD476EE6BBQ38099993-4CAA73BC-6ED7-4C43-AABE-8C89BC68B38CQ38132544-058AC8E6-1BDA-463E-87A3-3056FD3D4466Q38159887-1A4D6E4D-0D07-47F5-B6D7-0169A5DC710EQ38161591-F68BDCC0-CC01-42B0-A3C8-D9DED268063CQ38254357-68DF529D-7539-4274-9CC3-42A30170A800Q38627085-F823FC65-A575-4B93-B6A4-355A3F554D78Q38760855-567B6F23-E0D2-4256-9717-4BBE277AFA7AQ38765437-6A5E18A4-753B-402A-8CD1-5B0D68F39C85Q38862882-4FAAA84B-09FD-4FC5-8F1D-3EAC3739C009Q38994870-5A6540DA-006C-4820-B33D-CC908531B5F9Q39005837-D621B0D3-40E4-40D5-A8E7-6CB392F792C9Q39037445-01BD1275-C85D-4BFD-838F-58C5377BDA56Q39117775-600B6F0D-E886-44E0-A4F6-E127A1D5EC87Q39274731-B5C63F05-8A47-424D-8DC9-78E219602451Q39315998-F3795E85-1087-48DB-BFD6-A9A7236303E3Q39327405-B4FB89F0-2CC9-4153-9FE4-0980CEE9543CQ39481768-21C21243-C97D-4B97-A7DB-8155052FC7F0Q39527131-6FD85DA4-B1AF-400F-827C-F7EBBF29F6FCQ39790959-CEA50B09-3430-4F7C-A167-24CDE89DD222Q39823775-79210A7D-ED9E-462D-9707-7487CDF5DCB5Q40098836-1701D47D-1466-4E52-A9B2-7AB8E2A1023CQ40100270-9FB7CC3F-D1BC-464D-BBBF-2C6D85B70F5A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anette Müllertz
@ast
Anette Müllertz
@en
Anette Müllertz
@es
Anette Müllertz
@nl
Anette Müllertz
@sl
type
label
Anette Müllertz
@ast
Anette Müllertz
@en
Anette Müllertz
@es
Anette Müllertz
@nl
Anette Müllertz
@sl
prefLabel
Anette Müllertz
@ast
Anette Müllertz
@en
Anette Müllertz
@es
Anette Müllertz
@nl
Anette Müllertz
@sl
P106
P108
P1153
6603508227
P21
P31
P496
0000-0003-3020-8892